Home  |  Contact

Cellosaurus OPM-2/BR (CVCL_VJ35)

[Text version]

Cell line name OPM-2/BR
Synonyms OPM2/BR
Accession CVCL_VJ35
Resource Identification Initiative To cite this cell line use: OPM-2/BR (RRID:CVCL_VJ35)
Comments Characteristics: Produces Ig lambda.
Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
Derived from sampling site: Peripheral blood.
Sequence variations Heterozygous for CDKN2A p.His83Tyr (c.247C>T) (from parent cell line).
Heterozygous for FGFR3 p.Lys650Glu (c.1948A>G) (from parent cell line).
Heterozygous for SMAD2 p.Leu87Arg (c.260T>G) (from parent cell line).
Homozygous for TP53 p.Arg175His (c.524G>A) (from parent cell line).
Disease Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1625 (OPM-2)
Sex of cell Female
Age at sampling 56Y
Category Cancer cell line
Publications

PubMed=25382610; DOI=10.1038/bcj.2014.74
Chitta K.S., Paulus A., Caulfield T.R., Akhtar S., Blake M.-K.K., Ailawadhi S., Knight J., Heckman M.G., Pinkerton A., Chanan-Khan A.A.
Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenstroms macroglobulinemia.
Blood Cancer J. 4:E260-E260(2014)

Entry history
Entry creation07-Sep-2018
Last entry updated12-Mar-2020
Version number3